What Could Be Next in Treating Myeloma?

Published on

Topics include: Treatments and Understanding

Dr. Edward Libby, a hematologist/oncologist from Seattle Cancer Care Alliance, shares some of the major developing themes in treating myeloma and highlights the significance of monoclonal antibodies for patients with relapsed myeloma. Dr. Libby discusses how our understanding of smoldering myeloma is increasing and whether treatment should be given earlier. As a devoted myeloma specialist, Dr. Libby shares his gratification for patients who enter clinical trials to further myeloma research. 

View more programs featuring

Produced in association with

Related Programs

Research Efforts Focus on Increasing Treatment Response for Multiple Myeloma Patients

Dr. William Bensinger shares results from a study reported at ASH 2012 using an older drug, amifostine, in a new way; protecting patients from toxicity while patients receive higher and more effective doses of cancer-fighting drugs.


Improving Treatment for Advanced Myeloma

Dr. Meletios Dimopoulos reviews the vast changes in the treatment of myeloma and provides an upbeat assessment offering patients with more advanced myeloma new hope.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on January 14, 2014